Weight loss shots work by mimicking a gut hormone called GLP-1 that your body naturally releases after eating. The synthetic version is far more potent and longer-lasting than what your body produces on its own, creating a powerful effect on both your brain and your digestive system that reduces hunger, increases fullness, and slows how quickly food leaves your stomach. The result, in clinical trials, is weight loss ranging from 15% to 22.5% of body weight depending on the medication and dose.
Two Signals That Reduce Hunger
When you eat, your intestines release GLP-1 (glucagon-like peptide-1) to help manage blood sugar and signal fullness. Weight loss shots deliver a synthetic version of this hormone that works on two key parts of your brain simultaneously. First, it activates neurons in the brainstem that generate the “I’m full” feeling you get after a meal. Second, it silences a separate group of neurons in the hypothalamus, called AgRP neurons, that normally ramp up when you’re losing weight to tell your brain “you need to eat.”
That second effect is especially important. Under normal circumstances, when you cut calories and start losing weight, your AgRP neurons fire harder, driving intense hunger that makes dieting feel unsustainable. These medications suppress that compensatory hunger signal, which is a major reason people on the shots report that food simply occupies less mental space. They’re not white-knuckling through cravings. The biological alarm that usually fights weight loss is being turned down.
How Slower Digestion Adds to the Effect
Beyond the brain, these medications slow gastric emptying, the rate at which food moves from your stomach into your small intestine. When food sits in your stomach longer, you feel physically full for a longer period after eating, and your blood sugar rises more gradually. In one trial, 57% of patients on liraglutide (an older GLP-1 medication) developed measurably delayed gastric emptying compared to those on a placebo.
This slowed digestion is also the main source of side effects. Nausea, vomiting, and diarrhea affect 40% to 70% of people on these medications. The slowdown is most dramatic after the first dose, then gradually diminishes as your body adjusts, which is why doctors start at a low dose and increase it over several weeks.
Single vs. Dual Hormone Medications
Semaglutide (sold as Wegovy and Ozempic) targets only the GLP-1 receptor. Tirzepatide (sold as Zepbound and Mounjaro) targets both GLP-1 and a second gut hormone receptor called GIP. That dual action appears to produce greater weight loss. In the SURMOUNT-1 trial, participants on the highest dose of tirzepatide lost an average of 22.5% of their body weight, while semaglutide trials have typically shown losses in the 15% to 17% range.
The GIP component adds something unexpected. Research from Northwestern Medicine found that GIP, not GLP-1, is essential for transmitting signals to those appetite-regulating AgRP neurons in the hypothalamus. GIP receptors aren’t actually located on those neurons directly. Instead, GIP works through an indirect circuit, suggesting a more complex gut-brain communication pathway that researchers are still mapping out. Rodent studies have shown that combining GLP-1 and GIP hormones produces synergistic effects on energy intake and body weight that exceed what either hormone achieves alone.
What the Dosing Schedule Looks Like
Both medications are self-administered as a once-weekly injection, typically in the abdomen, thigh, or upper arm. The dose starts low and increases gradually over several months to give your body time to adjust and minimize side effects.
For semaglutide, you start at 0.25 mg per week, increasing by 0.25 mg every four weeks until reaching a target dose of 2.4 mg. That process takes roughly 16 to 20 weeks. Tirzepatide starts at 2.5 mg and increases by 2.5 mg every four weeks, up to a maximum of 15 mg. Your doctor may slow the escalation if side effects are difficult to manage at a given dose.
When Weight Loss Becomes Noticeable
There’s no universal timeline for when the scale starts moving. During the first several weeks, you’re on the lowest dose, and the medication is primarily helping your body acclimate. Most people notice reduced appetite before they notice significant weight loss. A useful benchmark from clinical data: if you’ve lost more than 5% of your body weight within the first three to four months, you’re on a trajectory that predicts sustained results at the 12-month mark. For tirzepatide specifically, losing 10% to 15% of body weight by six months is associated with maintaining that loss through at least one year of continued treatment.
Effects on Blood Sugar and Metabolism
These medications were originally developed for type 2 diabetes, and their metabolic effects go beyond weight loss. GLP-1 prompts the pancreas to release insulin in a glucose-dependent way, meaning it helps when blood sugar is high but doesn’t push it dangerously low. It also suppresses glucagon, a hormone that raises blood sugar, creating a double effect on glucose control.
In clinical trials, long-acting GLP-1 medications lowered hemoglobin A1c (a measure of average blood sugar over three months) by about 1 percentage point. That’s a clinically meaningful reduction, comparable to or slightly better than what insulin therapy achieves. There’s also evidence of cardiovascular benefits: GLP-1 reduces oxidative stress in blood vessels, decreases platelet activation, and inhibits processes involved in plaque formation. In the kidneys, it promotes sodium excretion, which can modestly lower blood pressure.
What Happens If You Stop
This is the part that surprises many people. A systematic review published in The Lancet found that within one year of stopping a GLP-1 medication, people regained 60% of the weight they had lost during treatment. The medications don’t reset your body’s weight set point. They suppress the hunger signals and slow digestion only while you’re taking them. Once the drug clears your system, those AgRP neurons in the hypothalamus reactivate, appetite returns to baseline, and digestion speeds back up.
This pattern is why many doctors now frame these medications as long-term, potentially lifelong treatment rather than a short course. The comparison often used is blood pressure medication: it works while you take it, and the underlying condition returns if you stop. Some people are able to maintain a portion of their weight loss through diet and exercise habits built during treatment, but the biological drive to regain is strong, and the data reflects that.